Dermatology Medical News about Keloid Pain

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Treatment of a Painful Keloid with Botulinum Toxin Type A
American Journal of Physical Medicine & Rehabilitation, 11/05/09

Uyesugi B et al. – Keloids are associated with small–fiber neuropathy and typically present with itching, pain, and allodynia. The following is a case presentation in which painful neuropathic symptoms from a keloid were treated successfully with botulinum toxin type A. To the authors' knowledge, this is the first such case report in the literature. Further research in the use of botulinum toxin to treat keloidal pain is warranted.

<< Previous
Fungicidal effect of photodynamic therapy against...

Next >>
Angiogenic and prothrombotic markers in extensive slow-flow...

Effects of Low-Level Laser Therapy on Pain and Scar Formation after Inguinal Herniation Surgery: A Randomized Controlled Single-Blind Study
Photomedicine and Laser Surgery, 10/16/09 Relevance Score: 65%

The relationship between disease activity, sleep, psychiatric distress and pain sensitivity in rheumatoid arthritis: A cross-sectional study
Arthritis Research & Therapy, 11/03/09 Relevance Score: 49%

Pain among Veterans of Operations Enduring Freedom and Iraqi Freedom: Do Women and Men Differ?
Pain Medicine, 10/13/09 Relevance Score: 49%

Prognosis for patients with chronic low back pain: inception cohort study
British Medical Journal, 10/09/09 Relevance Score: 49%

Corticosteroid Injection Treatment to the Ischiadic Spine Reduced Pain in Women With Long-Lasting Sacral Low Back Pain With Onset During Pregnancy: A Randomized, Double Blind, Controlled Trial
Spine, 10/01/09 Relevance Score: 49%